About Structure Therapeutics
Structure Therapeutics is a company based in San Francisco (United States) founded in 2017.. Structure Therapeutics has raised $233 million across 3 funding rounds from investors including WuXi AppTec, Citadel and Janus Henderson Investors. The company has 163 employees as of December 31, 2024. Structure Therapeutics operates in a competitive market with competitors including Sana Biotechnology, Semma Therapeutics, Adocia, Altimmune and Rezolute, among others.
- Headquarter San Francisco, United States
- Employees 163 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Structure Therapeutics, Inc. Sponsored Adr
-
Annual Revenue
$00as on Dec 31, 2024
-
Net Profit
$-122.59 M-36.9as on Dec 31, 2024
-
EBITDA
$-155.71 M-53.05as on Dec 31, 2024
-
Total Equity Funding
$233 M (USD)
in 3 rounds
-
Latest Funding Round
$33 M (USD), Series B
Aug 01, 2022
-
Investors
WuXi AppTec
& 18 more
-
Employee Count
163
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Structure Therapeutics
Structure Therapeutics is a publicly listed company on the NASDAQ with ticker symbol GPCR in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Funding Insights of Structure Therapeutics
Structure Therapeutics has successfully raised a total of $233M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $33 million completed in August 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series B — $33.0M
-
First Round
First Round
(19 Oct 2021)
- Investors Count 19
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2022 | Amount | Series B - Structure Therapeutics | Valuation |
investors |
|
| Oct, 2021 | Amount | Series B - Structure Therapeutics | Valuation | BVF Partners | |
| Oct, 2021 | Amount | Series D - Structure Therapeutics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Structure Therapeutics
Structure Therapeutics has secured backing from 19 investors, including venture fund and institutional investors. Prominent investors backing the company include WuXi AppTec, Citadel and Janus Henderson Investors. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Deep Track Capital is engaged in biotechnology investment activities.
|
Founded Year | Domain | Location | |
|
US private equity investments are managed by BVF Partners.
|
Founded Year | Domain | Location | |
|
Investing in Life Sciences sectors like Healthcare and Biotechnology.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Structure Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Structure Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Structure Therapeutics Comparisons
Competitors of Structure Therapeutics
Structure Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sana Biotechnology, Semma Therapeutics, Adocia, Altimmune and Rezolute, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Genetically engineered cell therapies are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
Provider of bio-artificial pancreas for Type 1 Diabetes treatment
|
|
| domain | founded_year | HQ Location |
Therapeutics for diabetes and obesity treatment are developed.
|
|
| domain | founded_year | HQ Location |
Vaccines for infectious diseases and solid tumors are developed.
|
|
| domain | founded_year | HQ Location |
Therapies for metabolic and orphan diseases are developed by Rezolute.
|
|
| domain | founded_year | HQ Location |
Disease-modifying therapies for metabolic diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Structure Therapeutics
Frequently Asked Questions about Structure Therapeutics
When was Structure Therapeutics founded?
Structure Therapeutics was founded in 2017 and raised its 1st funding round 4 years after it was founded.
Where is Structure Therapeutics located?
Structure Therapeutics is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Is Structure Therapeutics a funded company?
Structure Therapeutics is a funded company, having raised a total of $233M across 3 funding rounds to date. The company's 1st funding round was a Series D of $100M, raised on Oct 19, 2021.
How many employees does Structure Therapeutics have?
As of Dec 31, 2024, the latest employee count at Structure Therapeutics is 163.
What does Structure Therapeutics do?
Structure Therapeutics is engaged in the development of therapeutic solutions. The specific sectors or focus areas are not detailed on the site. Information regarding their pipeline or specific approaches remains undisclosed in the provided content. The company appears to operate within the healthcare or biotechnology field, though further details are not available.
Who are the top competitors of Structure Therapeutics?
Structure Therapeutics's top competitors include Sana Biotechnology, Semma Therapeutics and Adocia.
Is Structure Therapeutics publicly traded?
Yes, Structure Therapeutics is publicly traded on NASDAQ under the ticker symbol GPCR.
Who are Structure Therapeutics's investors?
Structure Therapeutics has 19 investors. Key investors include WuXi AppTec, Citadel, Janus Henderson Investors, Piper Sandler, and Qiming Venture Partners.
What is Structure Therapeutics's ticker symbol?
The ticker symbol of Structure Therapeutics is GPCR on NASDAQ.